CytomX Therapeutics Inc CTMX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:16 PM EDT
1.85quote price arrow down-0.02 (-1.07%)
Volume
2,196
Close
1.87quote price arrow down-0.05 (-2.60%)
Volume
1,486,970
52 week range
1.04 - 5.85
Loading...
  • Open1.93
  • Day High1.95
  • Day Low1.86
  • Prev Close1.92
  • 52 Week High5.85
  • 52 Week High Date05/01/24
  • 52 Week Low1.04
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap145.709M
  • Shares Out77.92M
  • 10 Day Average Volume12.18M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change20.65

KEY STATS

  • Open1.93
  • Day High1.95
  • Day Low1.86
  • Prev Close1.92
  • 52 Week High5.85
  • 52 Week High Date05/01/24
  • 52 Week Low1.04
  • 52 Week Low Date10/30/23
  • Market Cap145.709M
  • Shares Out77.92M
  • 10 Day Average Volume12.18M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change20.65

RATIOS/PROFITABILITY

  • EPS (TTM)0.20
  • P/E (TTM)9.45
  • Fwd P/E (NTM)-3.90
  • EBITDA (TTM)12.79M
  • ROE (TTM)-139.27%
  • Revenue (TTM)119.178M
  • Gross Margin (TTM)-
  • Net Margin (TTM)13.87%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CytomX Therapeutics Inc

 

Profile

MORE
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs)...
Sean Mccarthy Ph.D.
Chairman of the Board, Chief Executive Officer
Address
151 Oyster Point Blvd., Suite 400
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
RIGL
Rigel Pharmaceuticals Inc
0.914-0.0409-4.2832%
MCRB
Seres Therapeutics Inc
0.9101-0.0389-4.0991%
HBIO
Harvard Bioscience Inc
3.27UNCHUNCH
SPRO
Spero Therapeutics Inc
1.51-0.05-3.21%
RPTX
Repare Therapeutics Inc
3.40-0.08-2.30%